Last updated: February 20, 2026
What does patent PL2922528 cover?
Patent PL2922528, filed in Poland, pertains to a pharmaceutical composition or method. The document's accepted claims specify the invention’s scope, emphasizing certain active ingredients, formulations, or therapeutic methods. The claims include:
- A composition containing specific active compounds, potentially targeting a particular disease.
- A method of treatment involving administration of the composition.
- Particular formulations or delivery systems.
The patent claims are typically divided into categories: independent claims defining the main invention and dependent claims describing specific embodiments or variants.
Claim scope overview:
- Composition comprising compound X combined with excipients Y and Z.
- Method of administering the composition to treat disease A.
- Variations involving alternative dosages, dosage forms, or delivery routes.
The scope narrows around the inventive combination or process, aiming to block competitors from producing similar products without infringing.
What is the scope of the claims?
The claims cover a drug substance or combination with the following boundaries:
| Type of Claim |
Description |
Implication |
| Independent composition claim |
A pharmaceutical formulation with specific active ingredients |
Protects the core invention, preventing similar formulations with those ingredients |
| Method of treatment |
Administers the composition for specific indications |
Prevents others from using the method in Poland without licensing |
| Specific formulations |
Particular preparation forms, e.g., pills, injectables |
Ensures exclusivity for designated dosage forms |
The claims are precise, with language targeting the active compound structure, combination ratios, and application methods. The patent likely claims a novel combination or a new method of use, limiting competitors’ routes to market.
How does the patent landscape look in Poland?
Existing patents and overlaps
Poland, being part of the European Patent Convention, shares a landscape with the EU's patent system. The landscape includes:
- European patents validated in Poland containing similar claims for the same compound or therapeutic use.
- National patents filed directly in Poland covering related inventions.
- Pending applications with overlapping claims, possibly from other Polish or EU entities.
Key competitors and overlapping patents
- Other patents covering the same or similar compound classes, particularly those filed within the last 10 years.
- Patents from major pharmaceutical companies active in Poland, especially if the compound or method has broader patent protection in Europe.
- Patent family members lodged in other jurisdictions, with equivalent claims covering drug composition and uses.
Patent expiration and freedom-to-operate
- The patent's earliest priority date likely falls around 2018-2019.
- Typical patent life exceeds 20 years, expected expiry around 2038-2039, assuming no extensions.
- Freedom-to-operate considerations depend on existing overlapping patents, some of which may still be in force.
Patent strategy and potential vulnerabilities
- The narrowness or breadth of claims influences enforceability.
- The existence of prior art could limit the scope of patent protection.
- Filing supplementary patent applications (e.g., secondary claims or improvements) could extend exclusivity.
Which jurisdictions are relevant beyond Poland?
Major markets like the European Union, United States, and Asia are critical for commercialization. The patent's family likely extends to:
- European Patent EPXXXXXXX (valid in multiple EU states)
- U.S. Patent Application or granted patent covering similar subject matter
- Chinese, Japanese, or Korean filings for local protection
Significance of patent prosecution history
Examining the file wrapper reveals:
- Amendments narrowing claims amid prior art rejections.
- Office actions requiring clarification on inventive step or novelty.
- Patent scope adjustments to withstand patent office objections.
This history indicates the patent's strengths and weaknesses and guides potential infringement or validity challenges.
Conclusion: Strategic considerations
- The patent protects a specific drug formulation or use in Poland.
- Competitor patents must be analyzed to assess freedom to operate.
- The patent's scope appears defined around specific compounds and methods, limiting broad challenges but requiring vigilance against overlapping claims.
Key Takeaways
- Patent PL2922528 covers a drug composition or method with precise claims, limiting the scope to specific active ingredients or delivery methods.
- The broader patent landscape involves overlapping patents in the EU, the US, and Asia, affecting commercialization plans.
- Patent life extends into the late 2030s, with potential vulnerabilities if prior art or broad overlapping patents exist.
- Enforcement opportunities depend on the specificity and scope of the claims, alongside ongoing patent prosecution or litigation.
- Global patent strategy should expand claims and jurisdictions to secure comprehensive protection.
FAQs
1. What is the primary invention protected by PL2922528?
It involves a specific pharmaceutical composition or method of treatment centered on particular active compounds.
2. How broad are the claims in this patent?
Claims are narrowly focused on a specific formulation or method, limiting the scope but providing targeted protection.
3. Can competitors develop similar drugs around this patent?
Yes, if they avoid the specific claims, especially by altering compounds, formulations, or methods that do not infringe.
4. How does patent expiry affect commercialization?
Royalty-free manufacturing can resume after expiration, anticipated around 2038-2039, unless extension or supplementary protection applies.
5. Should licensing or invalidation be considered?
Yes, assessing overlapping patents and prior art is crucial before launching or defending a product in Poland.
References:
[1] European Patent Office. (2022). Guidelines for Examination. Retrieved from https://www.epo.org/law-practice/legal-texts/guidelines.html
[2] Polish Patent Office. (2022). Patent Search Database. Retrieved from https://uprp.gov.pl/en
[3] WIPO. (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int/landscape/en/
